Akari Therapeutics PLC (AKTX)
1.50
+0.01
(+0.67%)
USD |
NASDAQ |
May 14, 16:00
Akari Therapeutics Cash and Short Term Investments (Quarterly): 3.845M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.845M |
| June 30, 2023 | 7.181M |
| June 30, 2022 | 8.151M |
| March 31, 2022 | 16.72M |
| December 31, 2021 | 9.361M |
| September 30, 2021 | 13.39M |
| June 30, 2021 | 3.792M |
| March 31, 2021 | 6.668M |
| December 31, 2020 | 14.06M |
| September 30, 2020 | 12.32M |
| June 30, 2020 | 12.75M |
| March 31, 2020 | 7.822M |
| December 31, 2019 | 5.732M |
| September 30, 2019 | 6.269M |
| June 30, 2019 | 2.737M |
| March 31, 2019 | 6.146M |
| December 31, 2018 | 5.446M |
| Date | Value |
|---|---|
| September 30, 2018 | 10.07M |
| June 30, 2018 | 15.07M |
| March 31, 2018 | 23.78M |
| December 31, 2017 | 28.11M |
| September 30, 2017 | 20.97M |
| June 30, 2017 | 30.12M |
| March 31, 2017 | 34.94M |
| December 31, 2016 | 44.12M |
| September 30, 2016 | 50.63M |
| June 30, 2016 | 55.78M |
| March 31, 2016 | 61.43M |
| December 31, 2015 | 68.92M |
| September 30, 2015 | 78.77M |
| June 30, 2015 | 2.718M |
| March 31, 2015 | 4.016M |
| December 31, 2014 | 3.328M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
2.737M
Minimum
Jun 2019
16.72M
Maximum
Mar 2022
8.719M
Average
7.822M
Median
Mar 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| DBV Technologies SA | 101.52M |
| Cellectis SA | 203.82M |
| Adaptimmune Therapeutics PLC | 146.94M |
| Biodexa Pharmaceuticals Plc | 7.606M |
| NuCana PLC | 21.94M |